TIGERMED (03347) announced that in light of governance structure adjustments introduced by the proposed amendments and to ensure compliant board operations, Mr. Wu Hao, an executive director, was elected as an employee director for the company's fifth board of directors through an employee representative meeting held on August 28, 2025. His term will commence from the date when shareholders approve the proposed amendments and continue until the expiration of the company's fifth board of directors term. Mr. Wu Hao will also continue serving as an executive director and member of the Board Strategic Development Committee.